Search Results - "Bekassy, A"

Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy by Ljungman, P, Locasciulli, A, de Soria, V G, Békássy, A N, Brinch, L, Espigado, I, Ferrant, A, Franklin, I M, O'Riordan, J, Rovira, M, Shaw, P, Einsele, H

“…This prospective study was initiated in 1993 with the aim to study late effects and responses to antiviral therapy in a cohort of hepatitis C virus…”
Get full text

Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation by MILLOT, F, GUILHOT, J, GUILHOT, F, SUTTORP, M, NELKEN, B, LEBLANC, T, DE BONT, E. S, BEKASSY, A. N, GADNER, H, SUFLIARSKA, S, STARY, J, GSCHJIDMEIER, H

“…A multicentric phase 2 study was conducted to determine the efficiency and the tolerance of imatinib mesylate in children with chronic myelogenous leukemia…”
Get full text

Use of intrathecal chemoprophylaxis in children after SCT and the risk of central nervous system relapse by Rubin, J, Vettenranta, K, Vettenranta, J, Bierings, M, Abrahamsson, J, Békássy, A N, Håkansson, Y, Frost, B-M, Arvidson, J, Spendilow, C, Winiarski, J, Gustafsson, B

“…Conflicting conclusions can be drawn from the available data concerning antileukemic efficacy and risks of intrathecal (i.t.) chemoprophylaxis to children…”
Get full text

Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation by Tichelli, Andre, Passweg, Jakob, Wojcik, Dorota, Rovo, Alicia, Harousseau, Jean-Luc, Masszi, Tamas, Zander, Axel, Bekassy, Albert, Crawley, Charles, Arat, Mutlu, Sica, Simona, Lutz, Patrick, Socie, Gerard, on behalf of EBMT Late Effects Working Party

“…1 Dept. of Hematology, University Hospital, Basel, Switzerland 2 Service d’Hematologie, Hopitaux Universitaires de Genève, Geneva, Switzerland 3 Dept. of…”
Get full text

A novel and cytogenetically cryptic t(7;21)(p22;q22) in acute myeloid leukemia results in fusion of RUNX1 with the ubiquitin-specific protease gene USP42 by Paulsson, K, Békássy, A N, Olofsson, T, Mitelman, F, Johansson, B, Panagopoulos, I

“…Although many of the chromosomal abnormalities in hematologic malignancies are identifiable cytogenetically, some are only detectable using molecular methods…”
Get full text

Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors : a study on behalf of the European Group for Blood and Marrow Transplantation by GUARDIOLA, P, PASQUINI, R, LJUNGMAN, P, MINIERO, R, SHAW, P. J, SOUILLET, G, MICHALLET, M, BEKASSY, A. N, KRIVAN, G, DI BARTOLOMEO, P, HEILMANN, C, ZANESCO, L, DOKAL, I, CAHN, J. Y, ARCESE, W, BACIGALUPO, A, GLUCKMAN, E, ORTEGA, J. J, VAN WEEL-SIPMAN, M, MARSH, J. C. W, BALL, S. E, LOCATELLI, F, VERMYLEN, C, SKINNER, R

“…Allogeneic stem cell transplantation is the only treatment that can restore a normal hematopoiesis in Fanconi anemia (FA). In this retrospective multicenter…”
Get full text

No Disadvantage in Outcome of Using Matched Unrelated Donors as Compared With Matched Sibling Donors for Bone Marrow Transplantation in Children With Acute Lymphoblastic Leukemia in Second Remission by Saarinen-Pihkala, U M, Gustafsson, G, Ringdén, O, Heilmann, C, Glomstein, A, Lönnerholm, G, Abrahamsson, J, Bekassy, A N, Schroeder, H, Mellander, L

“…We evaluated the outcome of children with acute lymphoblastic leukemia (ALL) in second remission (2CR), comparing bone marrow transplantation (BMT) using…”
Get full text

Management of acquired aplastic anemia in children by Korthof, E T, Békássy, A N, Hussein, A A

“…The diagnosis of aplastic anemia in children requires exclusion of a variety of inherited or acquired BM failure syndromes with similar phenotypes. An…”
Get full text

Recent improvement in outcome of unrelated donor transplantation for aplastic anemia by Viollier, R, Socié, G, Tichelli, A, Bacigalupo, A, Korthof, E T, Marsh, J, Cornish, J, Ljungman, P, Oneto, R, Békássy, A N, Fuehrer, M, Maury, S, Schrezenmeier, H, van Lint, M T, Wojcik, D, Locasciulli, A, Passweg, J R

“…The aim was to determine whether outcome of unrelated donor transplantation for severe aplastic anemia has improved in recent years and whether this is due to…”
Get full text

Cytogenetic and FISH studies of a single center consecutive series of 152 childhood acute lymphoblastic leukemias by Andreasson, Patrik, Höglund, Mattias, Békássy, Albert N., Garwicz, Stanislaw, Heldrup, Jesper, Mitelman, Felix, Johansson, Bertil

“…: Between 1977 and 1996, cytogenetic investigations were performed on 182 childhood (16 yr) acute lymphoblastic leukemias (ALL), constituting 94% (182 of 194)…”
Get full text

Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipients by SANDSTRÖM, M, KARLSSON, M. O, LJUNGMAN, P, HASSAN, Z, JONSSON, E. N, NILSSON, C, RINGDEN, O, ÖBERG, G, BEKASSY, A, HASSAN, M

“…The aims of the present study were (1) to investigate and quantify the pharmacokinetics, including inter-occasion variability and covariate relationships, of…”
Get full text

Endocrinological late complications after hematopoietic SCT in children by Cohen, A, Békássy, A N, Gaiero, A, Faraci, M, Zecca, S, Tichelli, A, Dini, G

“…The main challenge for a pediatric hemato-oncologist today is to obtain a cure for the sick child with the minimum of treatment-related complications. Children…”
Get full text

Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene by Wijker, M, Morgan, N V, Herterich, S, van Berkel, C G, Tipping, A J, Gross, H J, Gille, J J, Pals, G, Savino, M, Altay, C, Mohan, S, Dokal, I, Cavenagh, J, Marsh, J, van Weel, M, Ortega, J J, Schuler, D, Samochatova, E, Karwacki, M, Bekassy, A N, Abecasis, M, Ebell, W, Kwee, M L, de Ravel, T, CG Mathew

“…Fanconi anaemia (FA) is a genetically heterogeneous autosomal recessive disorder associated with chromosomal fragility, bone-marrow failure, congenital…”
Get full text

Non-endocrine late complications in children after allogeneic haematopoietic SCT by Faraci, M, Békássy, A N, De Fazio, V, Tichelli, A, Dini, G

“…Non-endocrine events represent a heterogeneous group of complications occurring in children who survive long term after haematopoietic SCT. This review…”
Get full text

Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group by Stegmaier, S, Leuschner, I, Aakcha-Rudel, E, Münch, P, Kazanowska, B, Bekassy, A, Treuner, J, Koscielniak, E

“…Chromosomal translocations t(11;22) (q24;q12) are characteristic of about 80-90 % of Ewing's sarcoma family of tumors [bone and soft tissue Ewing's sarcoma and…”
Get more information

Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology by HASSAN, M, ÖBERG, G, SIMONSSON, B, BEKASSY, A. N, ASCHAN, J, EHRSSON, H, LJUNGMAN, P, LÖNNERHOLM, G, SMEDMYR, B, TAUBE, A, WALLIN, I

“…Busulphan levels in plasma were measured in 27 patients during conditioning therapy (1 mg/kg x 4 for 4 days) before bone marrow transplantation. The mean…”
Get full text

The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite : time interval influence on therapeutic efficacy and therapy-related toxicity by HASSAN, M, LJUNGMAN, P, ASTNER, L, RINGDEN, O, HASSAN, Z, ÖBERG, G, NILSSON, C, BEKASSY, A, BIELENSTEIN, M, ABDEL-REHIM, M, GEOREN, S

“…Busulphan and cyclophosphamide (Bu/CP) are widely used in preparative regimens for bone marrow transplantation. Many studies have shown a wide variation in…”
Get full text

Abnormalities on brain MR images during the course of familial haemophagocytic lymphohistocytosis in a child. A case report by Sundgren, P C, Geijer, B, Békássy, A N, Dictor, M

“…To describe and report the neuroradiological findings and clinical features in a patient with familial haemophagocytic lymphohistocytosis (FHL), a rare…”
Get more information

Salvage treatment of relapsing Wilms' tumour by autologous bone marrow transplantation by Kullendorff, C M, Békássy, A N

“…Despite the remarkable success in treatment of Wilms' tumour there is still a small group who will suffer from relapse. The optimal therapy for relapsing Wilms…”
Get more information

High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients by LJUNGMAN, P, HASSAN, M, BEKASSY, A. N, RINGDEN, O, ÖBERG, G

“…The aim of this study was to investigate the importance of busulfan concentrations for short- and long-term survival in autologous (ABMT) and allogeneic (BMT)…”
Get full text